448 related articles for article (PubMed ID: 11747550)
1. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
4. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest.
Roublevskaia IN; Haake AR; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):149-56. PubMed ID: 11345021
[TBL] [Abstract][Full Text] [Related]
6. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain).
Staniszewski A; Slesak B; Kołodziej J; Harłozińska-Szmyrka A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():63-7. PubMed ID: 1305047
[TBL] [Abstract][Full Text] [Related]
8. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
[TBL] [Abstract][Full Text] [Related]
10. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
Boyko VN; Zholus RB
Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
[TBL] [Abstract][Full Text] [Related]
11. Differential response of tumor cells and normal fibroblasts to fractionated combined treatment with topotecan and ionizing radiation.
Ohneseit PA; Wildemann A; Herskind C; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Feb; 78(2):125-32. PubMed ID: 11779362
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells in vitro.
Cordes N; Blaese MA; Plasswilm L; Rodemann HP; Van Beuningen D
Int J Radiat Biol; 2003 Sep; 79(9):709-20. PubMed ID: 14703944
[TBL] [Abstract][Full Text] [Related]
13. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
Slesak B; Nowicky JW; Harłozinska A
Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
[TBL] [Abstract][Full Text] [Related]
15. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle effects of topotecan alone and in combination with irradiation.
Ohneseit PA; Prager D; Kehlbach R; Rodemann HP
Radiother Oncol; 2005 May; 75(2):237-45. PubMed ID: 15890420
[TBL] [Abstract][Full Text] [Related]
17. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
[TBL] [Abstract][Full Text] [Related]
18. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control.
Strunz AM; Peschke P; Waldeck W; Ehemann V; Kissel M; Debus J
Int J Radiat Biol; 2002 Aug; 78(8):721-32. PubMed ID: 12194756
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
20. Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis.
Enns L; Bogen KT; Wizniak J; Murtha AD; Weinfeld M
Mol Cancer Res; 2004 Oct; 2(10):557-66. PubMed ID: 15498930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
